Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $284.85 | 16 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $151.90 | 8 | $0 (2024) |
| Janssen Biotech, Inc. | $88.98 | 6 | $0 (2020) |
| GlaxoSmithKline, LLC. | $25.07 | 1 | $0 (2021) |
| Dermavant Sciences, Inc. | $18.90 | 1 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $33.83 | 2 | ABBVIE INC. ($33.83) |
| 2023 | $32.20 | 2 | Dermavant Sciences, Inc. ($18.90) |
| 2022 | $61.30 | 3 | ABBVIE INC. ($61.30) |
| 2021 | $68.54 | 3 | AbbVie Inc. ($43.47) |
| 2020 | $12.69 | 1 | Janssen Biotech, Inc. ($12.69) |
| 2019 | $76.29 | 5 | Janssen Biotech, Inc. ($76.29) |
All Payment Transactions
16 individual payment records from CMS Open Payments
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 11/11/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $14.59 | General |
| Category: IMMUNOLOGY | ||||||
| 08/20/2024 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $19.24 | General |
| Category: IMMUNOLOGY | ||||||
| 06/12/2023 | ABBVIE INC. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $13.30 | General |
| Category: IMMUNOLOGY | ||||||
| 03/02/2023 | Dermavant Sciences, Inc. | VTAMA (Drug) | Food and Beverage | In-kind items and services | $18.90 | General |
| Category: DERMATOLOGY | ||||||
| 03/11/2022 | ABBVIE INC. | HUMIRA (Biological) | Food and Beverage | In-kind items and services | $16.82 | General |
| Category: IMMUNOLOGY | ||||||
| 02/28/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.25 | General |
| Category: IMMUNOLOGY | ||||||
| 02/10/2022 | ABBVIE INC. | RINVOQ (Biological) | Food and Beverage | In-kind items and services | $22.23 | General |
| Category: IMMUNOLOGY | ||||||
| 09/22/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $27.53 | General |
| Category: IMMUNOLOGY | ||||||
| 04/30/2021 | AbbVie Inc. | SKYRIZI (Biological) | Food and Beverage | In-kind items and services | $15.94 | General |
| Category: IMMUNOLOGY | ||||||
| 02/10/2021 | GlaxoSmithKline, LLC. | BENLYSTA (Biological) | Food and Beverage | In-kind items and services | $25.07 | General |
| Category: IMMUNOLOGY | ||||||
| 03/03/2020 | Janssen Biotech, Inc. | REMICADE (Biological), STELARA, SIMPONI | Food and Beverage | In-kind items and services | $12.69 | General |
| Category: Immunology | ||||||
| 12/02/2019 | Janssen Biotech, Inc. | SIMPONI (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Immunology | ||||||
| 11/04/2019 | Janssen Biotech, Inc. | SIMPONI (Biological) | Food and Beverage | In-kind items and services | $15.05 | General |
| Category: Immunology | ||||||
| 09/04/2019 | Janssen Biotech, Inc. | SIMPONI (Biological) | Food and Beverage | In-kind items and services | $13.00 | General |
| Category: Immunology | ||||||
| 07/29/2019 | Janssen Biotech, Inc. | SIMPONI (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Immunology | ||||||
| 05/31/2019 | Janssen Biotech, Inc. | SIMPONI (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Immunology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 13 | 1,254 | 1,934 | $199,165 | $81,461 |
| 2022 | 11 | 1,188 | 1,887 | $175,560 | $77,631 |
| 2021 | 12 | 814 | 1,212 | $122,495 | $61,149 |
| 2020 | 11 | 565 | 882 | $84,395 | $39,447 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 2 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99203 | New patient outpatient visit, total time 30-44 minutes | Office | 2021 | 110 | 110 | $15,400 | $8,453 | 54.9% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2021 | 86 | 93 | $11,160 | $6,926 | 62.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 46 | 69 | $10,140 | $6,580 | 64.9% |
| 17110 | Destruction of up to 14 skin growths | Office | 2021 | 70 | 77 | $11,550 | $6,078 | 52.6% |
| 17000 | Destruction of skin growth | Office | 2021 | 105 | 118 | $14,160 | $4,678 | 33.0% |
| 17004 | Destruction of 15 or more premalignant skin growths | Office | 2021 | 28 | 34 | $9,350 | $4,196 | 44.9% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2021 | 15 | 17 | $4,080 | $1,848 | 45.3% |
| 17003 | Destruction of 2-14 skin growths | Office | 2021 | 69 | 344 | $12,040 | $1,658 | 13.8% |
| 99212 | Established patient outpatient visit, total time 10-19 minutes | Office | 2021 | 34 | 36 | $2,670 | $1,491 | 55.8% |
| 99202 | New patient outpatient visit, total time 15-29 minutes | Office | 2021 | 32 | 32 | $3,040 | $1,463 | 48.1% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2021 | 14 | 17 | $1,360 | $700.72 | 51.5% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 124 | 149 | $18,625 | $11,152 | 59.9% |
| 99203 | New patient office or other outpatient visit, typically 30 minutes | Office | 2020 | 65 | 65 | $9,100 | $4,799 | 52.7% |
| 11102 | Tangential biopsy of single skin lesion | Office | 2020 | 56 | 67 | $8,040 | $4,361 | 54.2% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 65 | 80 | $7,600 | $3,975 | 52.3% |
| 17000 | Destruction of skin growth | Office | 2020 | 72 | 83 | $9,960 | $3,289 | 33.0% |
| 99202 | New patient office or other outpatient visit, typically 20 minutes | Office | 2020 | 51 | 51 | $4,845 | $2,704 | 55.8% |
| 17110 | Destruction of up to 14 skin growths | Office | 2020 | 34 | 35 | $5,250 | $2,688 | 51.2% |
| 17004 | Destruction of 15 or more skin growths | Office | 2020 | 15 | 18 | $4,950 | $2,084 | 42.1% |
| 17262 | Destruction of malignant growth (1.1 to 2.0 centimeters) of trunk, arms, or legs | Office | 2020 | 11 | 15 | $3,600 | $1,890 | 52.5% |
| 17003 | Destruction of 2-14 skin growths | Office | 2020 | 52 | 291 | $10,185 | $1,329 | 13.0% |
| 11103 | Tangential biopsy of additional skin lesion | Office | 2020 | 20 | 28 | $2,240 | $1,177 | 52.5% |
About Dr. Michael Osofsky, MD
Dr. Michael Osofsky, MD is a Dermatology healthcare provider based in Coraopolis, Pennsylvania. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/03/2008. The National Provider Identifier (NPI) number assigned to this provider is 1376706945.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Michael Osofsky, MD has received a total of $284.85 in payments from pharmaceutical and medical device companies, with $33.83 received in 2024. These payments were reported across 16 transactions from 4 companies. The most common payment nature is "Food and Beverage" ($284.85).
As a Medicare-enrolled provider, Osofsky has provided services to 3,821 Medicare beneficiaries, totaling 5,915 services with total Medicare billing of $259,689. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Dermatology
- Location Coraopolis, PA
- Active Since 07/03/2008
- Last Updated 09/26/2019
- Taxonomy Code 207N00000X
- Entity Type Individual
- NPI Number 1376706945
Products in Payments
- SKYRIZI (Biological) $90.60
- SIMPONI (Biological) $76.29
- RINVOQ (Biological) $44.48
- BENLYSTA (Biological) $25.07
- VTAMA (Drug) $18.90
- HUMIRA (Biological) $16.82
- REMICADE (Biological) $12.69
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Dermatology Doctors in Coraopolis
Dr. Brian Pucevich, M.d, M.D
Dermatology — Payments: $15,748
Maria Pucevich, Md, MD
Dermatology — Payments: $12,108
Dr. Damon Mcclain, M.d, M.D
Dermatology — Payments: $5,859
Dr. Susannah Berke, Md, MD
Dermatology — Payments: $5,381